U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 14, 2005 NUTRA PHARMA CORP. (Exact name of registrant as specified in its charter) California 000-32141 91-2021600 (State or jurisdiction of (Commission (I.R.S. Employer incorporation or organization) File Number) Identification No.) 1829 Corporate Dr. Boynton Beach, Florida 33426 (Address of principal executive offices) (Zip Code) Registrant's telephone number: 954-509-0911 ------------------------------------------------------ (Former name or former address, if changed since last report) Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On January 14, 2005, Nutra Pharma Corp.'s Board of Directors approved the appointment of Dr. Tanvir Khandaker to its Board of Directors. Biographical Information - Dr. Tanvir Khandaker From January 2002 to January 2005, Dr. Khandaker was the President and a Director of Khandaker Partners, an independent research firm located in New York, New York, which specializes in fundamental analysis of public companies. From January 1999 to December 2001, Dr. Khandaker was a Research Associate at the Brigham and Women's Hospital of the Harvard Medical School and from January 1998 to December 1999, Dr. Khandaker was a Research Associate at the Massachusetts General Hospital of the Harvard Medical School. In December 1995, Dr. Khandaker received a medical degree from the Robert Mitford Medical College located in Dhaka, Bangladesh, and from January 1996 to April 1997, he was a Resident in Internal Medicine and Surgery at Robert Mitford Medical College. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 20, 2005 Nutra Pharma Corp. /s/ Rik Deitsch By: Rik Deitsch, Chief Executive Officer/Director
- NPHC Dashboard
- Financials
- Filings
- Insider
- Institutional
- Patents
-
8-K Filing
Nutra Pharma (NPHC) 8-KDeparture of Directors or Principal Officers
Filed: 20 Jan 05, 12:00am